Opendata, web and dolomites

CONTRA SIGNED

Computational ONcology TRaining Alliance

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CONTRA project word cloud

Explore the words cloud of the CONTRA project. It provides you a very rough idea of what is the project "CONTRA" about.

drug    nevertheless    intersection    analysing    recruitment    lie    evolution    suffering    excellent    social    joined    collectively    somatic    tackle    begun    insights    sequencing    expertise    biomarker    data    software    heterogeneity    genders    teach    commercial    15    force    diagnosis    initially    situation    academic    patients    medical    survival    death    public    substantial    fail    unleash    struggle    rectify    treatment    assaying    forces    training    pharmaceutical    computational    security    25    contra    researched    scheme    genomic    modern    frequently    innovative    thereby    complementary    huge    cell    single    unprecedented    rendering    subsequently    industry    esrs    durable    molecular    components    train    employments    cancer    spatial    last    biotech    mathematical    biology    combination    complemented    tumour    industrial    opportunity    skills    consequently    evolutionary    successful    techniques    posed    geographical    entrepreneurship    fortunately   

Project "CONTRA" data sheet

The following table provides information about the project.

Coordinator
KUNGLIGA TEKNISKA HOEGSKOLAN 

Organization address
address: BRINELLVAGEN 8
city: STOCKHOLM
postcode: 100 44
website: www.kth.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 3˙863˙978 €
 EC max contribution 3˙863˙978 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KUNGLIGA TEKNISKA HOEGSKOLAN SE (STOCKHOLM) coordinator 527˙318.00
2    KING'S COLLEGE LONDON UK (LONDON) participant 546˙575.00
3    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) participant 546˙575.00
4    EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH CH (ZUERICH) participant 530˙453.00
5    FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) ES (BARCELONA) participant 495˙745.00
6    UNIVERSIDAD DE VIGO ES (VIGO PONTEVEDRA) participant 495˙745.00
7    UNIWERSYTET WARSZAWSKI PL (WARSZAWA) participant 448˙274.00
8    THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL UK (LONDON) participant 273˙287.00
9    Ardigen SA PL (Kraków) partner 0.00
10    British Columbia Cancer Agency Branch CA (Vancouver) partner 0.00
11    FUNDACION CENTRO TECNOLOXICO DE TELECOMUNICACIONS DE GALICIA ES (VIGO) partner 0.00
12    Merck KGaA DE (DARMSTADT) partner 0.00
13    Seven Bridges Genomics UK Limited UK (LONDON) partner 0.00
14    Spatial Transcriptomics AB SE (Solna) partner 0.00
15    TORUS SOFTWARE SOLUTIONS S.L. ES (A CORUNA) partner 0.00

Map

 Project objective

Cancer is a major cause of death and suffering, rendering it a huge concern to the general public. Consequently, it has been targeted by application of the molecular techniques developed during the last 20-25 years, thereby improving diagnosis and treatment. Nevertheless, although current biomarker and treatment concepts often are successful initially, they subsequently frequently fail to achieve durable drug response and long-term survival for cancer patients. The study of somatic evolution in cancer is a very promising approach to rectify this situation. Fortunately, single cell genomic sequencing has recently begun to provide opportunity to unprecedented detailed insights into tumour evolution and new techniques are emerging for assaying the spatial distribution of tumour heterogeneity. Analysing and developing methods for these emerging data sets are under-researched areas that lie at the intersection of medical, evolutionary biology, and computational research. In CONTRA, European researchers with complementary expertise have joined forces in order to collectively facilitate training of future European computational cancer researchers. We will by applying modern recruitment and selection methods in combination with offering excellent training and employments conditions, including social security, facilitate recruitment of 15 excellent ESRs, across genders and geographical areas. We will train these 15 ESRs in the mathematical, computational, and applied skills required to tackle the complex analysis problems posed by somatic evolution in cancer. We will also teach them entrepreneurship and the requirements of pharmaceutical and biotech industry. Using a novel scheme, this substantial academic cancer expertise will be complemented with industrial expertise in software development, especially for biotech and pharmaceutical industry, which will unleash key components of the innovative force of the European commercial sector in the struggle against cancer.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CONTRA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CONTRA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

PARACAT (2019)

Paramagnetic Species in Catalysis Research. A Unified Approach Towards Heterogeneous, Homogeneous and Enzyme Catalysis

Read More  

ARCH (2019)

AGE-RELATED CHANGES IN HEMATOPOIESIS

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More